Arch Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Arch Therapeutics generated cash of -$3,374,216, which is more than the previous year. Cash used in financing activities reached the amount of $2,854,517 last year. Net change in cash is therefore -$524,220.
Cash Flow
| 2014 | -3.34M | 0 | 3.62M |
|---|---|---|---|
| 2015 | -4.23M | 0 | 7.36M |
| 2016 | -4.74M | 0 | 5.82M |
| 2017 | -5.61M | -8.68K | 6.58M |
| 2018 | -5.91M | -15.41K | 4.60M |
| 2019 | -5.26M | 0 | 2.78M |
| 2020 | -5.04M | -2.45K | 3.82M |
| 2021 | -5.95M | -3.27K | 7.26M |
| 2022 | -4.45M | 0 | 2.93M |
| 2023 | -3.37M | -4.52K | 2.85M |
ARTH Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 746.94K | 2.26M | 959.30K | 2.18M | 4.66M | 5.99M | 5.03M | 3.96M | 833.52K | 557.31K |
Operating activities | ||||||||||
Net income | -6.98M | -5.27M | -6.24M | -4.69M | -4.54M | -4.81M | -7.78M | -5.99M | -2.94M | -8.14M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.96K | 3.19K | 2.58K | 6.92K | 8.23K | 5.34K | 1.49K | 0 | 0 | 322 |
Stock-based compensation expense | 249.55K | 499.58K | 496.06K | 898.29K | 1.18M | 0 | 2.10M | 1.09M | 1.04M | 1.10M |
| Deferred income tax benefit | 249.55K | 499.58K | 496.06K | 898.29K | 1.18M | 0 | 2.10M | 1.09M | 1.04M | 1.10M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 50.34K | -569.15K | -307.76K | -681.73K | -346.64K | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 976.20K | 846.86K | 66.03K | -191.50K | 372.60K | -103.93K | -110.02K | 137.42K | 55.92K | -138.93K |
Cash generated by operating activities | -3.37M | -4.45M | -5.95M | -5.04M | -5.26M | -5.91M | -5.61M | -4.74M | -4.23M | -3.34M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -4.52K | 0 | -3.27K | -2.45K | 0 | -15.41K | -8.68K | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -4.52K | 0 | -3.27K | -2.45K | 0 | -15.41K | -8.68K | 0 | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 2.20M | 8.95K | 6.21M | 2.16M | 2.74M | 4.46M | 5.98M | 0 | 3.01M | 2.62M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 995K | 3.04M | -1.05M | -726.3K | 0 | 0 | -1M | 0 | 750K | 0 |
Cash used in financing activities | 2.85M | 2.93M | 7.26M | 3.82M | 2.78M | 4.60M | 6.58M | 5.82M | 7.36M | 3.62M |
Net Change In Cash | -524.22K | -1.51M | 1.30M | -1.22M | -2.48M | -1.32M | 957.57K | 1.07M | 3.12M | 276.20K |
Cash at end of period | 222.72K | 746.94K | 2.26M | 959.30K | 2.18M | 4.66M | 5.99M | 5.03M | 3.96M | 833.52K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |